GALENA BIOPHARMA INC's ticker is GALEXXXX and the CUSIP is 363256108. A total of 90 filers reported holding GALENA BIOPHARMA INC in Q3 2014. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2016 | $8,000 | -20.0% | 23,219 | 0.0% | 0.00% | – |
Q2 2016 | $10,000 | -68.8% | 23,219 | 0.0% | 0.00% | – |
Q1 2016 | $32,000 | -5.9% | 23,219 | 0.0% | 0.00% | – |
Q4 2015 | $34,000 | -2.9% | 23,219 | 0.0% | 0.00% | – |
Q3 2015 | $35,000 | -10.3% | 23,219 | 0.0% | 0.00% | – |
Q2 2015 | $39,000 | +18.2% | 23,219 | 0.0% | 0.00% | – |
Q1 2015 | $33,000 | -5.7% | 23,219 | 0.0% | 0.00% | – |
Q4 2014 | $35,000 | -28.6% | 23,219 | 0.0% | 0.00% | – |
Q3 2014 | $49,000 | – | 23,219 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 5,446,469 | $13,616,000 | 2.03% |
Harbour Capital Advisors, LLC | 78,450 | $196,000 | 0.19% |
SABBY MANAGEMENT, LLC | 708,089 | $1,770,000 | 0.10% |
TENOR CAPITAL MANAGEMENT Co., L.P. | 174,600 | $437,000 | 0.07% |
Alyeska Investment Group, L.P. | 530,000 | $1,950,000 | 0.05% |
HIGHLAND CAPITAL MANAGEMENT LP | 528,027 | $1,320,000 | 0.05% |
KMS FINANCIAL SERVICES, INC | 118,042 | $295,000 | 0.05% |
Quantitative Investment Management, LLC | 348,500 | $871,000 | 0.04% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 538,100 | $1,345,000 | 0.04% |
DUMONT & BLAKE INVESTMENT ADVISORS LLC | 29,675 | $74,000 | 0.04% |